Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mackensen

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Science Translational Medicine|April 10, 2015
Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphomaHeiko Bruns, Maike Büttner, Mario Fabri, et al.
Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
Frontiers in Immunology|March 29, 2020
Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine EndopeptidaseAnita N Kremer, Judith Bausenwein, Ellie Lurvink, et al.
Annals of the Rheumatic Diseases|July 23, 2025
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosusPanagiotis Garantziotis, Lorenzo Beretta, Julius Lindblom, et al.
Plos Pathogens|April 22, 2022
Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITLMaría Fernanda Lammoglia Cobo, Julia Ritter, Regina Gary, et al.
Oncoimmunology|May 8, 2015
Identification and characterization of the specific murine NK cell subset supporting graft-<i>versus</i>-leukemia- and reducing graft-<i>versus</i>-host-effectsKathrin Meinhardt, Irena Kroeger, Ruth Bauer, et al.
Cancers|December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer CenterLars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Med (New York, N.Y.)|April 10, 2026
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndromeIsabel K Korte, Soraya Kharboutli, Simon Völkl, et al.
Oncoimmunology|September 14, 2016
Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cellsFrederik C Henrich, Katrin Singer, Kerstin Poller, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Science Translational Medicine|April 10, 2015
Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphomaHeiko Bruns, Maike Büttner, Mario Fabri, et al.
Cancers|November 13, 2021
Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular SubtypesRamona Erber, Sareetha Kailayangiri, Hanna Huebner, et al.
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
Frontiers in Immunology|March 29, 2020
Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine EndopeptidaseAnita N Kremer, Judith Bausenwein, Ellie Lurvink, et al.
Annals of the Rheumatic Diseases|July 23, 2025
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosusPanagiotis Garantziotis, Lorenzo Beretta, Julius Lindblom, et al.
Plos Pathogens|April 22, 2022
Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITLMaría Fernanda Lammoglia Cobo, Julia Ritter, Regina Gary, et al.
Oncoimmunology|May 8, 2015
Identification and characterization of the specific murine NK cell subset supporting graft-<i>versus</i>-leukemia- and reducing graft-<i>versus</i>-host-effectsKathrin Meinhardt, Irena Kroeger, Ruth Bauer, et al.
Cancers|December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer CenterLars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Med (New York, N.Y.)|April 10, 2026
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndromeIsabel K Korte, Soraya Kharboutli, Simon Völkl, et al.
Oncoimmunology|September 14, 2016
Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cellsFrederik C Henrich, Katrin Singer, Kerstin Poller, et al.
Pageof 20